ey0016.9-5 | Metabolic and Cardiovascular Risk in Cancer Survivors | ESPEYB16
R Nakagawa
, A Hosokawa-Tsuji
, Y Aoki
, K Takasawa
, M Maru
, K Nakajima
, A Sutani
, Y Miyakawa
, D Tomizawa
, K Kashimada
, T Morio
To read the full abstract: Endocrine. 2018 Jul; 61(1):76Hematopoietic stem cell transplantation (HSCT) is a curative treatment for life-threatening malignancies. However, late HSCT adverse effects cause substantial morbidity among long-term survivors. Metabolic complications, such as diabetes mellitus and hyperlipidemia, are the major late effects of pediatric HSCT, but the pathogenesis ...